Questions across 5 calls

Sanjay Kular

ACME Private Limited

Natco Pharma Limited

Natco Pharma Limited CC-Jun24.pdf · 2024-08-13

Yes. Congratulations for giving good results, Sir, you are an entrepreneur. As an entrepreneur, we always see that our wealth should be best measured in terms of market cap. You know, companies like your size which earns nearly INR2,000 crores are quoting aro und INR80,000 crores to INR1 lakh crores market cap. So what do you think other reasons why we enjoy little less market cap? And what are the measures should be taken to increase the market here?

Sorry, sir, that is the reason I think we should enjoy at least 45 multiple, but we are enjoying just 10, 12. You know, previously mentioned...

Inox Wind Limited

Inox Wind Limited CC-Jun24.pdf · 2024-08-09

Mr. Jain, first of all, I would like to compliment to you and your team for extraordinary turnaround and rewarding shareholders with a liberal bonus issue in the first year of turnaround itself. You are truly visionary next -gen entrepreneur who has created unprecedented wealth on the seat. My question is only one, which is very simple. What is the key differentiated we will have with our peer group company in terms of execution or in terms of profitability? Would you like to share some thoughts?

Divi's Laboratories Limited

Divi's Laboratories Limited CC-Mar24.pdf · 2024-05-25

Okay. Complements to you for delivering excellent results, madam. My questions are following. Madam, you said we are going to spend ₹1,500 crores capex for current year -- next year. So how much sales we expect to generate from that? I mean, asset turn? Then second question is that we have done long-term agreement with a multinational. So it has opened opportunities to enter into more tie-ups with other multinationals. So are we talking to some more multinationals for such tie-ups? And the third question is madam, what is the vision for next 3 to 5 years? Can we become $2 billion, $3 billion revenue company going forward?

Okay, madam. Any more such tie-ups with MNCs likely.

Gujarat Fluorochemicals Limited

Gujarat Fluorochemicals Limited CC-Dec23.pdf · 2024-02-07

Sir, again, my question is on the same topic, which is FY'25 EBITDA will be greater than FY'23. So sir, are you confirming the guidance again in this con call?

Okay. Thanks. [Next Session]

Sun Pharmaceutical Industries Limited

Sun Pharmaceutical Industries Limited CC-Dec23.pdf ·

First of all, compliments to the whole team for giving excellent results. Sir, in the light of good results in Q3 and overall 9 months performance, are you planning to increase guidance for the current year and for the next year? That is 1 question. Second question is, you are a company sitting on $2 billion of cash and cash equivalents plus we are generating annual cash flow of $1 billion plus. So are we planning to give giving back excess cash to shareholders by way of buybacks or increased dividends? For further updates and specific queries, please visit www.sunpharma.com or feel free to contact Abhishek Sharma, +91 22 43242929, abhi.sharma@sunpharma.com, Gaurav Chugh, +91 22 43245373, gaurav.chugh@sunpharma.com,